SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms

U. Bedi, A. H. Scheel, M. Hennion, Y. Begus-Nahrmann, J. Rüschoff, Steven Johnsen

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The estrogen receptor alpha (ERα) is the central transcriptional regulator of ductal mammary epithelial lineage specification and is an important prognostic marker in human breast cancer. Although antiestrogen therapies are initially highly effective at treating ERα-positive tumors, a large number of tumors progress to a refractory, more poorly differentiated phenotype accompanied by reduced survival. A better understanding of the molecular mechanisms involved in the progression from estrogen-dependent to hormone-resistant breast cancer may uncover new targets for treatment and the discovery of new predictive markers. Recent studies have uncovered an important role for transcriptional elongation and chromatin modifications in controlling ERα activity and estrogen responsiveness. The human Suppressor of Ty Homologue-6 (SUPT6H) is a histone chaperone that links transcriptional elongation to changes in chromatin structure. We show that SUPT6H is required for estrogen-regulated transcription and the maintenance of chromatin structure in breast cancer cells, possibly in part through interaction with RNF40 and regulation of histone H2B monoubiquitination (H2Bub1). Moreover, we demonstrate that SUPT6H protein levels decrease with malignancy in breast cancer. Consistently, SUPT6H, similar to H2Bub1, is required for cellular differentiation and suppression of the repressive histone mark H3K27me3 on lineage-specific genes. Together, these data identify SUPT6H as a new epigenetic regulator of ERα activity and cellular differentiation.

Original languageEnglish (US)
Pages (from-to)465-473
Number of pages9
JournalOncogene
Volume34
Issue number4
DOIs
StatePublished - Jan 22 2015
Externally publishedYes

Fingerprint

Estrogen Receptor alpha
Epigenomics
Estrogen Receptors
Breast Neoplasms
Chromatin
Estrogens
Histone Code
Histone Chaperones
Neoplasms
Estrogen Receptor Modulators
Histones
Breast
Maintenance
Hormones
Phenotype
Survival
Genes
Proteins
Therapeutics

Keywords

  • breast cancer
  • chromatin
  • differentiation
  • Estrogen receptor

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms. / Bedi, U.; Scheel, A. H.; Hennion, M.; Begus-Nahrmann, Y.; Rüschoff, J.; Johnsen, Steven.

In: Oncogene, Vol. 34, No. 4, 22.01.2015, p. 465-473.

Research output: Contribution to journalArticle

Bedi, U. ; Scheel, A. H. ; Hennion, M. ; Begus-Nahrmann, Y. ; Rüschoff, J. ; Johnsen, Steven. / SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms. In: Oncogene. 2015 ; Vol. 34, No. 4. pp. 465-473.
@article{fb9f9ff722c04d888e30004232fc96ed,
title = "SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms",
abstract = "The estrogen receptor alpha (ERα) is the central transcriptional regulator of ductal mammary epithelial lineage specification and is an important prognostic marker in human breast cancer. Although antiestrogen therapies are initially highly effective at treating ERα-positive tumors, a large number of tumors progress to a refractory, more poorly differentiated phenotype accompanied by reduced survival. A better understanding of the molecular mechanisms involved in the progression from estrogen-dependent to hormone-resistant breast cancer may uncover new targets for treatment and the discovery of new predictive markers. Recent studies have uncovered an important role for transcriptional elongation and chromatin modifications in controlling ERα activity and estrogen responsiveness. The human Suppressor of Ty Homologue-6 (SUPT6H) is a histone chaperone that links transcriptional elongation to changes in chromatin structure. We show that SUPT6H is required for estrogen-regulated transcription and the maintenance of chromatin structure in breast cancer cells, possibly in part through interaction with RNF40 and regulation of histone H2B monoubiquitination (H2Bub1). Moreover, we demonstrate that SUPT6H protein levels decrease with malignancy in breast cancer. Consistently, SUPT6H, similar to H2Bub1, is required for cellular differentiation and suppression of the repressive histone mark H3K27me3 on lineage-specific genes. Together, these data identify SUPT6H as a new epigenetic regulator of ERα activity and cellular differentiation.",
keywords = "breast cancer, chromatin, differentiation, Estrogen receptor",
author = "U. Bedi and Scheel, {A. H.} and M. Hennion and Y. Begus-Nahrmann and J. R{\"u}schoff and Steven Johnsen",
year = "2015",
month = "1",
day = "22",
doi = "10.1038/onc.2013.558",
language = "English (US)",
volume = "34",
pages = "465--473",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms

AU - Bedi, U.

AU - Scheel, A. H.

AU - Hennion, M.

AU - Begus-Nahrmann, Y.

AU - Rüschoff, J.

AU - Johnsen, Steven

PY - 2015/1/22

Y1 - 2015/1/22

N2 - The estrogen receptor alpha (ERα) is the central transcriptional regulator of ductal mammary epithelial lineage specification and is an important prognostic marker in human breast cancer. Although antiestrogen therapies are initially highly effective at treating ERα-positive tumors, a large number of tumors progress to a refractory, more poorly differentiated phenotype accompanied by reduced survival. A better understanding of the molecular mechanisms involved in the progression from estrogen-dependent to hormone-resistant breast cancer may uncover new targets for treatment and the discovery of new predictive markers. Recent studies have uncovered an important role for transcriptional elongation and chromatin modifications in controlling ERα activity and estrogen responsiveness. The human Suppressor of Ty Homologue-6 (SUPT6H) is a histone chaperone that links transcriptional elongation to changes in chromatin structure. We show that SUPT6H is required for estrogen-regulated transcription and the maintenance of chromatin structure in breast cancer cells, possibly in part through interaction with RNF40 and regulation of histone H2B monoubiquitination (H2Bub1). Moreover, we demonstrate that SUPT6H protein levels decrease with malignancy in breast cancer. Consistently, SUPT6H, similar to H2Bub1, is required for cellular differentiation and suppression of the repressive histone mark H3K27me3 on lineage-specific genes. Together, these data identify SUPT6H as a new epigenetic regulator of ERα activity and cellular differentiation.

AB - The estrogen receptor alpha (ERα) is the central transcriptional regulator of ductal mammary epithelial lineage specification and is an important prognostic marker in human breast cancer. Although antiestrogen therapies are initially highly effective at treating ERα-positive tumors, a large number of tumors progress to a refractory, more poorly differentiated phenotype accompanied by reduced survival. A better understanding of the molecular mechanisms involved in the progression from estrogen-dependent to hormone-resistant breast cancer may uncover new targets for treatment and the discovery of new predictive markers. Recent studies have uncovered an important role for transcriptional elongation and chromatin modifications in controlling ERα activity and estrogen responsiveness. The human Suppressor of Ty Homologue-6 (SUPT6H) is a histone chaperone that links transcriptional elongation to changes in chromatin structure. We show that SUPT6H is required for estrogen-regulated transcription and the maintenance of chromatin structure in breast cancer cells, possibly in part through interaction with RNF40 and regulation of histone H2B monoubiquitination (H2Bub1). Moreover, we demonstrate that SUPT6H protein levels decrease with malignancy in breast cancer. Consistently, SUPT6H, similar to H2Bub1, is required for cellular differentiation and suppression of the repressive histone mark H3K27me3 on lineage-specific genes. Together, these data identify SUPT6H as a new epigenetic regulator of ERα activity and cellular differentiation.

KW - breast cancer

KW - chromatin

KW - differentiation

KW - Estrogen receptor

UR - http://www.scopus.com/inward/record.url?scp=85028194690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028194690&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.558

DO - 10.1038/onc.2013.558

M3 - Article

C2 - 24441044

AN - SCOPUS:85028194690

VL - 34

SP - 465

EP - 473

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 4

ER -